Finesse Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 04-07-2024
- Paid Up Capital ₹ 4.09 M
as on 04-07-2024
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.88 Cr
as on 04-07-2024
- Satisfied Charges ₹ 2.15 M
as on 04-07-2024
- Revenue 97.86%
(FY 2022)
- Profit -35.21%
(FY 2022)
- Ebitda -104.81%
(FY 2022)
- Net Worth 53.15%
(FY 2022)
- Total Assets 26.80%
(FY 2022)
About Finesse Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 4.09 M.
The company currently has active open charges totaling ₹1.88 Cr. The company has closed loans amounting to ₹2.15 M, as per Ministry of Corporate Affairs (MCA) records.
Rajshree Kothari and Manthan Kothari serve as directors at the Company.
- CIN/LLPIN
U85100GJ1985PTC007568
- Company No.
007568
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Finesse Pharmaceuticals Private Limited offer?
Finesse Pharmaceuticals Private Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Inspection & Quality Check Services, Quality Inspection Service.
Who are the key members and board of directors at Finesse Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajshree Kothari  | Director | 03-Jan-2023 | Current |
| Manthan Kothari | Director | 06-Oct-2020 | Current |
Financial Performance and Corporate Structure Insights of Finesse Pharmaceuticals.
Finesse Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 97.86% increase. The company also saw a substantial fall in profitability, with a 35.21% decrease in profit. The company's net worth Soared by an impressive increase of 53.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finesse Pharmaceuticals?
Unlock access to Finesse Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ahmedabad Bariatrics And Cosmetics Private LimitedActive 13 years 10 monthsRajshree Kothari is a mutual person
Crazy Wings Entertainment Private LimitedActive 2 years 10 monthsRajshree Kothari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Apr 2007 | ₹0.41 M | Open |
Canara Bank Creation Date: 11 Feb 2006 | ₹1.83 Cr | Open |
Canara Bank Creation Date: 03 Oct 2011 | ₹1.15 M | Satisfied |
How Many Employees Work at Finesse Pharmaceuticals?
Finesse Pharmaceuticals has a workforce of 10 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Finesse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finesse Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
